Lorlatinib: A Targeted Therapy for ALK-Positive Lung Cancer Lorlatinib is a next-generation tyrosine kinase inhibitor (TKI) designed to treat ALK-positive non-small cell lung cancer (NSCLC). Approved by the FDA and…
What is Capmatinib? | Uses, Side Effects, and More Capmatinib (brand name: Tabrecta) is a targeted cancer therapy used primarily in the treatment of non-small cell lung cancer (NSCLC). It…
MoboCertinib: An Overview of its Uses, Benefits, and Side Effects What is MoboCertinib? MoboCertinib is an innovative medication used in the treatment of non-small cell lung cancer (NSCLC), particularly in…
Reviews
There are no reviews yet.